No Data
[Brokerage Focus] CITIC SEC: The integration of the Traditional Chinese Medicine Industry is accelerating, and the leading players are expected to strengthen their position.
Jinwu Financial News | CITIC SEC states that the price of Traditional Chinese Medicine materials has entered a downward channel, and improvements in industrial costs are worth anticipating. Starting in January 2025, Traditional Chinese Medicine companies will successively complete inventory clearance through channels, and numerous e-commerce activities will occur during the Spring Festival, with strong purchasing power among Consumers. The e-commerce platforms' sales of Pharmaceutical products generally achieve high year-on-year growth rates. Benefiting from policy support and the accelerated aging of the population, the bank expects that overall demand for Traditional Chinese Medicine will continue to improve in the future, with industry consolidation accelerating, and leading companies are likely to become stronger.
Hong Kong stock Concept tracking | Promoting the value assessment and allocation of Traditional Chinese Medicine Pharmaceuticals, Institutions are Bullish on the recovery of Traditional Chinese Medicine revenue (with attached Concept stocks)
The General Office of the State Council issued the "Opinions on Improving the Quality of Traditional Chinese Medicine and Promoting the High-Quality Development of the Traditional Chinese Medicine Industry."
Hong Kong stock movements | Some Traditional Chinese Medicine concept stocks opened higher, with TRAD CHI MED (00570) opening over 8% higher. The State Council has issued a document to promote the high-quality development of Traditional Chinese Medicine.
Some Traditional Chinese Medicine concept stocks opened higher. As of the time of writing, TRAD CHI MED (00570) rose by 8.06%, trading at 2.28 HKD; TONGRENTANGCM (03613) increased by 4.64%, trading at 9.02 HKD; and Gushengtang (02273) rose by 3.45%, trading at 41.95 HKD.
Hong Kong stock Concept Tracking | Important! The State Council has deployed measures to promote the high-quality development of Traditional Chinese Medicine Industry. Institutions are Bullish on the bottom reversal of the Industry (with related stocks).
The General Office of the State Council recently issued the 'Opinions on Improving the Quality of Traditional Chinese Medicine and Promoting the High-Quality Development of the Traditional Chinese Medicine Industry.'
Guoshengtang (02273.HK) will hold a Board of Directors meeting on March 31 to consider and approve the annual performance.
Gelonghui, on March 19, announced that Gushengtang (02273.HK) will hold a Board of Directors meeting on March 31, 2025 (Monday) to consider and approve the group's annual performance for the year ending December 31, 2024, and its publication, as well as to consider the proposal for a final dividend (if any).
GUSHENGTANG: DATE OF BOARD MEETING
Investors Give Zhejiang Crystal-Optech Co., Ltd (SZSE:002273) Shares A 27% Hiding
